abs

학술발표회초록보기

초록문의 abstract@kcsnet.or.kr

결제문의 member@kcsnet.or.kr

현재 가능한 작업은 아래와 같습니다.
  • 03월 03일 12시 이후 : 초록수정 불가능, 일정확인 및 검색만 가능

Urokinase Inhibitor Design using Ligand and Receptor Based Methods

등록일
2006년 2월 24일 18시 16분 04초
접수번호
1242
발표코드
33P461포 이곳을 클릭하시면 발표코드에 대한 설명을 보실 수 있습니다.
발표시간
금 <발표Ⅱ>
발표형식
포스터
발표분야
의약화학
저자 및
공동저자
Liu Shui, Kavitha Bharatham, Nagakumar Bharatham, 이근우
경상대학교 생화학과,
It is widely documented that the progression of cancer cell invasion and metastasis is hinged on the ability of tumor cells to produce and recruit proteolytic enzymes. All of the reported inhibitors of urokinase contain an amidine or guanidine group, and compounds designed from templates containing these positively charged moieties can be a liability in the search for oral therapeutic agents. Therefore, there is a need for alternative small-molecule inhibitors of urokinase which have favorable pharmacokinetic properties. In a search for such compounds we have a developed a database of 472 uPA inhibitory compounds and have taken advantage of two methods such as analogue(ligand) based and structure(receptor) based computational methods by pharmacophore hypothesis generation using CATALYST software and molecular docking using GOLD software respectively. The former method helped us to know the key 3D chemical features of the structure that are responsible for determining whether the compound is active or inactive. The later method helps us to know the binding orientation and the type of interactions at the active site.

상단으로